Production (Stage)
Diebold Nixdorf, Incorporated
DBD
$47.35
-$0.06-0.13%
NYSE
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Revenue | 841.10M | 988.90M | 927.10M | 939.70M | 895.40M |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | 841.10M | 988.90M | 927.10M | 939.70M | 895.40M |
Cost of Revenue | 627.90M | 752.50M | 685.30M | 695.70M | 669.80M |
Gross Profit | 213.20M | 236.40M | 241.80M | 244.00M | 225.60M |
SG&A Expenses | 145.00M | 126.00M | 154.10M | 143.80M | 144.90M |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -1.70M | -1.00M | -- | -- | -1.00M |
Total Operating Expenses | 791.50M | 899.80M | 862.30M | 862.10M | 834.90M |
Operating Income | 49.60M | 89.10M | 64.80M | 77.60M | 60.50M |
Income Before Tax | -9.70M | 11.90M | 8.20M | 46.80M | -17.10M |
Income Tax Expenses | -2.20M | 5.50M | 29.90M | 32.00M | -3.10M |
Earnings from Continuing Operations | -7.50M | 6.40M | -21.70M | 14.80M | -14.00M |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -800.00K | -800.00K | -700.00K | 100.00K | -600.00K |
Net Income | -8.30M | 5.60M | -22.40M | 14.90M | -14.60M |
EBIT | 49.60M | 89.10M | 64.80M | 77.60M | 60.50M |
EBITDA | 83.50M | 132.40M | 94.60M | 107.50M | 93.80M |
EPS Basic | -0.22 | 0.15 | -0.60 | 0.40 | -0.39 |
Normalized Basic EPS | 0.15 | 0.77 | 0.67 | 0.93 | 0.31 |
EPS Diluted | -0.22 | 0.15 | -0.60 | 0.40 | -0.39 |
Normalized Diluted EPS | 0.15 | 0.77 | 0.67 | 0.92 | 0.31 |
Average Basic Shares Outstanding | 37.60M | 37.60M | 37.60M | 37.60M | 37.60M |
Average Diluted Shares Outstanding | 37.60M | 37.60M | 37.60M | 37.70M | 37.60M |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |